345 related articles for article (PubMed ID: 7509439)
1. Characterization of the binding of [3H]substance P to the nicotinic acetylcholine receptor of Torpedo electroplaque.
Min CK; Owens J; Weiland GA
Mol Pharmacol; 1994 Feb; 45(2):221-7. PubMed ID: 7509439
[TBL] [Abstract][Full Text] [Related]
2. Effects of substance P on the binding of ligands to nicotinic acetylcholine receptors.
Weiland GA; Durkin JA; Henley JM; Simasko SM
Mol Pharmacol; 1987 Nov; 32(5):625-32. PubMed ID: 2446113
[TBL] [Abstract][Full Text] [Related]
3. Barbiturates bind to an allosteric regulatory site on nicotinic acetylcholine receptor-rich membranes.
Dodson BA; Braswell LM; Miller KW
Mol Pharmacol; 1987 Jul; 32(1):119-26. PubMed ID: 3600612
[TBL] [Abstract][Full Text] [Related]
4. Marked up-regulation of the beta-bungarotoxin site in adrenal chromaffin cells by specific nicotinic antagonists.
Quik M; Geertsen S; Trifaró JM
Mol Pharmacol; 1987 Apr; 31(4):385-91. PubMed ID: 3574287
[TBL] [Abstract][Full Text] [Related]
5. Regulation of alpha-bungarotoxin sites in chromaffin cells in culture by nicotinic receptor ligands, K+, and cAMP.
Geertsen S; Afar R; Trifaró JM; Quik M
Mol Pharmacol; 1988 Oct; 34(4):549-56. PubMed ID: 2459593
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of high-affinity nicotinic [3H]acetylcholine binding sites.
Lukas RJ
J Pharmacol Exp Ther; 1990 Apr; 253(1):51-7. PubMed ID: 2329523
[TBL] [Abstract][Full Text] [Related]
7. Substance P inhibits carbamylcholine-stimulated 22Na+ efflux from acetylcholine receptor-enriched Torpedo electroplaque membrane vesicles.
Min CK; Weiland GA
Brain Res; 1992 Jul; 586(2):348-51. PubMed ID: 1381656
[TBL] [Abstract][Full Text] [Related]
8. Association of a spin-labeled local anesthetic with the allosterically coupled noncompetitive inhibitor site on the acetylcholine receptor.
Palma A; Herz JM; Wang HH; Taylor P
Mol Pharmacol; 1986 Sep; 30(3):243-51. PubMed ID: 3018481
[TBL] [Abstract][Full Text] [Related]
9. Distribution of alpha-bungarotoxin binding sites over residues 173-204 of the alpha subunit of the acetylcholine receptor.
Wilson PT; Hawrot E; Lentz TL
Mol Pharmacol; 1988 Nov; 34(5):643-50. PubMed ID: 3193956
[TBL] [Abstract][Full Text] [Related]
10. Nicotinic pharmacology of anatoxin analogs. I. Side chain structure-activity relationships at peripheral agonist and noncompetitive antagonist sites.
Swanson KL; Aronstam RS; Wonnacott S; Rapoport H; Albuquerque EX
J Pharmacol Exp Ther; 1991 Oct; 259(1):377-86. PubMed ID: 1920124
[TBL] [Abstract][Full Text] [Related]
11. Localization of 3H-nicotine, 125I-kappa-bungarotoxin, and 125I-alpha-bungarotoxin binding to nicotinic sites in the chicken forebrain and midbrain.
Sorenson EM; Chiappinelli VA
J Comp Neurol; 1992 Sep; 323(1):1-12. PubMed ID: 1430311
[TBL] [Abstract][Full Text] [Related]
12. Binding sites for alpha-bungarotoxin and the noncompetitive inhibitor phencyclidine on a synthetic peptide comprising residues 172-227 of the alpha-subunit of the nicotinic acetylcholine receptor.
Donnelly-Roberts DL; Lentz TL
Biochemistry; 1991 Jul; 30(30):7484-91. PubMed ID: 1854749
[TBL] [Abstract][Full Text] [Related]
13. Synthetic peptides corresponding to sequences of snake venom neurotoxins and rabies virus glycoprotein bind to the nicotinic acetylcholine receptor.
Lentz TL; Hawrot E; Wilson PT
Proteins; 1987; 2(4):298-307. PubMed ID: 3448605
[TBL] [Abstract][Full Text] [Related]
14. The hydrophobic photoreagent 3-(trifluoromethyl)-3-m-([125I] iodophenyl) diazirine is a novel noncompetitive antagonist of the nicotinic acetylcholine receptor.
White BH; Howard S; Cohen SG; Cohen JB
J Biol Chem; 1991 Nov; 266(32):21595-607. PubMed ID: 1939189
[TBL] [Abstract][Full Text] [Related]
15. Direct effects of thymopentin (Arg-Lys-Asp-Val-Tyr) on cholinergic agonist-induced slow inactivation of nicotinic acetylcholine receptor function.
Ochoa EL; Li LA; Plummer A; McNamee MG
Mol Pharmacol; 1990 Dec; 38(6):863-71. PubMed ID: 2250665
[TBL] [Abstract][Full Text] [Related]
16. Photoactivatable agonist of the nicotinic acetylcholine receptor: potential probe to characterize the structural transitions of the acetylcholine binding site in different states of the receptor.
Chatrenet B; Kotzba-Hibert F; Mulle C; Changeux JP; Goeldner MP; Hirth C
Mol Pharmacol; 1992 Jun; 41(6):1100-6. PubMed ID: 1614412
[TBL] [Abstract][Full Text] [Related]
17. Desensitization of the nicotinic acetylcholine receptor by diisopropylfluorophosphate.
Eldefrawi ME; Schweizer G; Bakry NM; Valdes JJ
J Biochem Toxicol; 1988; 3():21-32. PubMed ID: 3236333
[TBL] [Abstract][Full Text] [Related]
18. d-Tubocurarine binding sites are located at alpha-gamma and alpha-delta subunit interfaces of the nicotinic acetylcholine receptor.
Pedersen SE; Cohen JB
Proc Natl Acad Sci U S A; 1990 Apr; 87(7):2785-9. PubMed ID: 2320589
[TBL] [Abstract][Full Text] [Related]
19. The acetylcholine receptor of the neuromuscular junction recognizes mecamylamine as a noncompetitive antagonist.
Varanda WA; Aracava Y; Sherby SM; VanMeter WG; Eldefrawi ME; Albuquerque EX
Mol Pharmacol; 1985 Aug; 28(2):128-37. PubMed ID: 2410768
[TBL] [Abstract][Full Text] [Related]
20. Nicotinic receptor-elicited sodium flux in rat pheochromocytoma PC12 cells: effects of agonists, antagonists, and noncompetitive blockers.
Daly JW; Nishizawa Y; Edwards MW; Waters JA; Aronstam RS
Neurochem Res; 1991 Apr; 16(4):489-500. PubMed ID: 1922660
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
